Tim‐3/galectin‐9 signaling pathway mediates T‐cell dysfunction and predicts poor prognosis in patients with hepatitis B virus‐associated hepatocellular carcinoma
Hang Li, Ke Wu, Kaixiong Tao, Libo Chen, Qichang Zheng, Xiaoming Lu, Jun Liu, Liang Shi, Chuanqiao Liu, Guobin Wang, Weiping Zou – 13 April 2012 – The interaction between T cell immunoglobulin‐ and mucin‐domain‐containing molecule (Tim‐3) expressed on T helper 1 (Th1) cells, and its ligand, galectin‐9, negatively regulates Th1‐mediated immune responses. However, it is poorly understood if and how the Tim‐3/galectin‐9 signaling pathway is involved in immune escape in patients with hepatocellular carcinoma (HCC).